Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment
about
Induced immunity against hepatitis B virusAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Vertical transmission of hepatitis B virus: challenges and solutionsHepatitis B virus: where do we stand and what is the next step for eradication?Infantile hepatitis B in immunized children: risk for fulminant hepatitis and long-term outcomes.Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
P2860
Q28080525-3A45F2E3-EC3A-43B9-8AEE-22E503A7C689Q30391932-2375A153-E642-4CF0-A0EE-405495AC8926Q33774099-F23B83FB-885B-42BA-BA32-ACA98B6E9820Q33958764-8964758D-8983-44B8-8225-7493E48442B3Q34472882-16D85681-2B63-4FD2-A8A8-B8EAF5FB5F05Q36179464-1B3EF590-26AF-439A-9625-25456FDFFA34Q37264961-251BCCB8-4638-4ADE-BFB4-9CDE603D04E7Q38240691-4A4EDA07-B0B3-49F0-BBAE-B4D61D732515Q38264269-934DC6C7-4E96-4D64-BD88-94B4A5F50398Q38631865-471C7ABA-C59E-4536-868B-497B187835D3Q39256818-CB333A8F-6F94-4207-B94F-3EED3D676A99Q40934257-E7DA4CA5-D1B6-4CF3-AA2B-4013462890A4Q53699968-6BC41FD7-CD03-48FF-906E-B2573E6C7FE2
P2860
Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@ast
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@en
Cost-effectiveness of augmenti ...... n with immunoglobin treatment.
@nl
type
label
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@ast
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@en
Cost-effectiveness of augmenti ...... n with immunoglobin treatment.
@nl
prefLabel
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@ast
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@en
Cost-effectiveness of augmenti ...... n with immunoglobin treatment.
@nl
P2093
P2860
P356
P1433
P1476
Cost-effectiveness of augmenti ...... on with immunoglobin treatment
@en
P2093
Jennifer M Yeh
Jung-Der Wang
Mehlika Toy
Stephen Resch
P2860
P304
P356
10.1542/PEDS.2012-1262
P407
P577
2013-03-25T00:00:00Z